Effects of postoperative morbidity on long-term outcome following surgery for colorectal liver metastases

World Journal of Surgery

Volumn 39, Issue 2, 2015, Pages 478-486

  Lodewick, T M ^a,b,c   De Jong, M C ^a,b   Van Dam, R M ^a,b   Bemelmans, M H A ^a,b   Olde Damink, S W M ^a,b,d   Dejong, C H C ^a,b   Neumann, U P ^c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE EFFECTS; AGED; CANCER STAGING; COLORECTAL TUMOR; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER NEOPLASMS; LIVER RESECTION; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84921937164     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-014-2799-1     Document Type: Article

References (45)

1. Pawlik TM, Schulick RD, Choti MA (2008) Expanding criteria for resectability of colorectal liver metastases. Oncologist 13:51-64
2. Bengmark S, Hafstrom L (1969) The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 23:198-202
3. Pestana C, Reitemeier RJ, Moertel CG et al (1964) The natural history of carcinoma of the colon and rectum. Am J Surg 108:826-829
4. Falcone A, Ricci S, Brunetti I et al (2007) Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol 25:1670-1676
5. van Iersel LB, Koopman M, van de Velde CJ et al (2010) Management of isolated nonresectable liver metastases in colorectal cancer patients: a case-control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy. Ann Oncol 21:1662-1667
6. de Jong MC, Pulitano C, Ribero D et al (2009) Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 250:440-448
7. Morris EJ, Forman D, Thomas JD et al (2010) Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg 97:1110-1118
8. Choti MA, Sitzmann JV, Tiburi MF et al (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759-766
9. Jones RP, Jackson R, Dunne DF et al (2012) Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases. Br J Surg 99:477-486
10. Wei AC, Greig PD, Grant D et al (2006) Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol 13:668-676
11. Schiesser M, Chen JW, Maddern GJ et al (2008) Perioperative morbidity affects long-term survival in patients following liver resection for colorectal metastases. J Gastrointest Surg 12: 1054-1060
12. van Dam RM, Lodewick TM, van den Broek MA et al (2013) Outcomes of extended versus limited indications for patients undergoing a liver resection for colorectal cancer liver metastases. HPB (Oxford). doi:10.1111/hpb.12181
13. Cescon M, Vetrone G, Grazi GL et al (2009) Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. Ann Surg 249:995-1002
14. Fong Y, Cohen AM, Fortner JG et al (1997) Liver resection for colorectal metastases. J Clin Oncol 15:938-946
15. Belghiti J, Hiramatsu K, Benoist S et al (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38-46
16. Jarnagin WR, Gonen M, Fong Y et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236:397-406
17. de Haas RJ, Wicherts DA, Andreani P et al (2011) Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection. Ann Surg 253:1069-1079
18. Virani S, Michaelson JS, Hutter MM et al (2007) Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg 204:1284-1292
19. Laurent C, Sa Cunha A, Couderc P et al (2003) Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg 90:1131-1136
20. Ito H, Are C, Gonen M et al (2008) Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg 247:994-1002
21. Tanaka K, Kumamoto T, Nojiri K et al (2010) Impact of postoperative morbidity on long-term survival after resection for colorectal liver metastases. Ann Surg Oncol. doi:10.1245/s10434-010-1352-1
22. Law WL, Choi HK, Lee YM et al (2007) The impact of postoperative complications on long-term outcomes following curative resection for colorectal cancer. Ann Surg Oncol 14:2559-2566
23. McArdle CS, McMillan DC, Hole DJ (2005) Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer. Br J Surg 92:1150-1154
24. Hirai T, Yamashita Y, Mukaida H et al (1998) Poor prognosis in esophageal cancer patients with postoperative complications. Surg Today 28:576-579
25. Takeuchi H, Saikawa Y, Oyama T et al (2010) Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy. World J Surg 34:277-284
26. de Melo GM, Ribeiro KC, Kowalski LP et al (2001) Risk factors for postoperative complications in oral cancer and their prognostic implications. Arch Otolaryngol Head Neck Surg 127:828-833
27. Vigano L, Ferrero A, Lo Tesoriere R et al (2008) Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol 15:2458-2464
28. Farid SG, Aldouri A, Morris-Stiff G et al (2010) Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis. Ann Surg 251:91-100
29. Schepers A, Mieog S, van de Burg BB et al (2010) Impact of complications after surgery for colorectal liver metastasis on patient survival. J Surg Res 164:e91-e97
30. Schnitzbauer AA, Lang SA, Goessmann H et al (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255:405-414
31. Neumann UP, Dejong CH (2013) Split decision. Br J Surg 100:310-312
32. van de Poll MC, Siroen MP, van Leeuwen PA et al (2007) Interorgan amino acid exchange in humans: consequences for arginine and citrulline metabolism. Am J Clin Nutr 85:167-172
33. Dejong CHC, Garden OJ (2003) Neoplasms of the liver. In: Majid AA, Kingsnorth A (eds) Advanced surgical practice. Greenwich Medical Media, London, pp 146-156
34. van Dam RM, Hendry PO, Coolsen MM et al (2008) Initial experience with a multimodal enhanced recovery programme in patients undergoing liver resection. Br J Surg 95:969-975
35. Marang-van de Mheen PJ, Stadlander MC, Kievit J (2006) Adverse outcomes in surgical patients: implementation of a nationwide reporting system. Qual Saf Health Care 15:320-324
36. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205-213
37. van den Broek MA, van Dam RM, van Breukelen GJ et al (2011) Development of a composite endpoint for randomized controlled trials in liver surgery. Br J Surg 98:1138-1145
38. Ferenci P, Lockwood A, Mullen K et al (2002) Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35:716-721
39. Rahbari NN, Garden OJ, Padbury R et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713-724
40. Rahbari NN, Garden OJ, Padbury R et al (2011) Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS). HPB (Oxford) 13:528-535
41. Burkon P, Slampa P, Kazda T et al (2012) Stereotactic body radiation therapy for colorectal cancer liver metastases; early results. Klin Onkol 25 Suppl 2:2S93-97
42. Kress MS, Collins BT, Collins SP et al (2012) Stereotactic body radiation therapy for liver metastases from colorectal cancer: analysis of safety, feasibility, and early outcomes. Front Oncol 2:8
43. Pathak S, Jones R, Tang JM et al (2011) Ablative therapies for colorectal liver metastases: a systematic review. Colorectal Dis 13:e252-e265
44. Kulik U, Bektas H, Klempnauer J et al (2013) Repeat liver resection for colorectal metastases. Br J Surg 100:926-932
45. Pitt HA, Kilbane M, Strasberg SM et al (2009) ACS-NSQIP has the potential to create an HPB-NSQIP option. HPB (Oxford) 11:405-413